Search Results - "van Laake, L.W"

Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles by van den Akker, F., Vrijsen, K.R., Deddens, J.C., Buikema, J.W., Mokry, M., van Laake, L.W., Doevendans, P.A., Sluijter, J.P.G.

“…Adverse remodeling after myocardial infarction (MI) is strongly influenced by T cells. Stem cell therapy after MI, using mesenchymal stem cells (MSC) or…”
Get full text

An exceptionally large coronary artery aneurysm in a formerly healthy young woman by Du Pré, B.C., Van Laake, L.W., Velthuis, B.K., de Waal, E.E.C., Buijsrogge, M.P., Hassink, R.J.

Get full text

Usefulness and Applicability of Femorofemoral Crossover Bypass Grafting by Thuijls, Geertje, van Laake, L.W, Lemson, M.S, Kitslaar, P.J

“…We examined the usefulness of femorofemoral crossover bypass grafting (FFC) and factors influencing its outcome by retrospectively analyzing all FFCs performed…”
Get full text

(118) Heart Donation and Transplantation of Circulatory Death Donors: The Dutch Experience by van der Kaaij, N.P., Manintveld, O.C., Taverne, Y.J., Damman, K., Van Laake, L.W., Erasmus, M.E.

“…Shortage of donor hearts can be reduced using hearts of circulatory death donors. In 2015, initiatives were taken to start a DCD heart transplantation program…”
Get full text

(1007) Clinical Relevance and Outcome of Routine Endomyocardial Biopsy to Detect Rejection after Heart Transplantation by Kieviet, L.C., Szymanski, M.K., van der Meer, M.G., van der Kaaij, N.P., de Jonge, N., van Laake, L.W., Oerlemans, M.I.

“…After heart transplantation (HTx), endomyocardial biopsies (EMBs) are the gold standard to monitor cardiac allograft rejection. However, a clear consensus on…”
Get full text

Predictors of late right heart failure after mechanical circulatory support by Felix, S, Oerlemans, M.I.F, Asselbergs, F.W, Van Laake, L.W, De Jonge, N

“…Abstract Introduction Right heart failure (RHF) is associated with a worse outcome in mechanical circulatory support (MCS). Several studies have identified…”
Get full text

(1238) - Preoperative Amiodarone Use Does Not Affect Pacemaker Implantation After Heart Transplantation by Vels, A.E., Kieviet, L.C., Szymanski, M.K., van der Meer, M.G., van der Kaaij, N.P., Van Laake, L.W., Tuinenburg, A.E., Jacob, K.A., van Aarnhem, E.E., Oerlemans, M.I.

Get full text

(1152) - Ex Vivo Myocardial Slices Unveil Reversibility in Chemotherapy-Induced Cardiotoxicity by Kelters, I.R., van der Geest, J.S., Sampaio-Pinto, V., Zwetsloot, P.M., Teske, A.J., De Boer, T.P., van der Kaaij, N.P., Sluijter, J.P., Van Laake, L.W.

Get full text

Predictive Role of Soluble ST2 in Patients on Left Ventricular Assist Device Support by Numan, L., Aarts, E., Ramjankhan, F.Z., van der Meer, M.G., Jonge, N.D., Oppelaar, A., Asselbergs, F.W., van Laake, L.W.

“…Soluble suppression of tumorigenicity-2 (sST2) is a prognostic indicator for mortality in heart failure (HF) patients and therefore a valuable tool in risk…”
Get full text

Characteristics and Outcome of COVID-19 Infection in Heart Transplantation Recipients in the Netherlands by Muller, S.A., Manintveld, O.C., Szymanski, M.K., Damman, K., van der Meer, M.G., Caliskan, K., van Laake, L.W., Oerlemans, M.I.

“…Immunocompromised patients are at high-risk for complicated COVID-19 infection. The aim of this study is to describe the characteristics and outcome of heart…”
Get full text

The Value of Physiotherapeutic Tests Next to Cardiopulmonary Exercise Test to Assess Exercise Capacity in Left Ventricular Assist Device Patients by Muller, S.A., Felix, S.E., Rommens, C., de Jonge, N., Szymanski, M.K., Gianoli, M., Ramjankhan, F.Z., van Laake, L.W., Oerlemans, M.I.

“…Quality of life in advanced heart failure patients treated with left ventricular assist device (LVAD) is largely determined by exercise capacity, for which…”
Get full text

(834) Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients by Numan, L., Aarts, E., Ramjankhan, F., Van Der Meer, M.G., Oerlemans, M., De Jonge, N., Oppelaar, A., Kemperman, H., Asselbergs, F., Van Laake, L.W.

“…Soluble suppression of tumorigenicity-2 (sST2) predicts all-cause mortality in patients with heart failure (HF). However, the predictive value of sST2…”
Get full text

(497) - Ultrastructural Characteristics of Porcine and Human Hearts During Normothermic Ex Situ Heart Perfusion by Vervoorn, M.T., Scheren, A.S., Van Tuijl, S., Ballan, E.M., Van der Kraak, P.H., Kaffka Genaamd Dengler, S.E., De Jager, S.C., Goldschmeding, R., Vink, A., Sluijter, J.P., Doevendans, P.A., Van Laake, L.W., van der Kaaij, N.P.

Get full text

Systemic Dilation Diathesis in Patients with Abdominal Aortic Aneurysms: A Role for Matrix Metalloproteinase-9? by van Laake, L.W., Vainas, T., Dammers, R., Kitslaar, P.J.E.H.M., Hoeks, A.P.G., Schurink, G.W.H.

“…Accumulating evidence suggests that patients with abdominal aortic aneurysm (AAA) suffer from a systemic dilating condition affecting all arteries. Matrix…”
Get full text

Utilidad del bypass protésico femorofemoral cruzado by Thuijls, Geertje, van Laake, L.W., Lemson, M.S., Kitslaar, P.J.

Get full text

Utilidad del bypass protésico femorofemoral cruzado by Thuijls, Geertje, van Laake, L.W., Lemson, M.S., Kitslaar, P.J.

“…Examinamos la utilidad del bypass protésico femorofemoral cruzado (FFC), y los factores que influyen en su resultado, analizando de forma retrospectiva los…”
Get full text